WEBCAST: New England CEPAC Meeting Tardive Dyskinesia

Event Information

Share this event

Date and Time

Friends Who Are Going
Event description


The New England Comparative Effectiveness Public Advisory Council (New England CEPAC), a core program of the Institute for Clinical and Economic Review (ICER), is a nationally-recognized community forum. The New England CEPAC convenes three times each year at public meetings to review objective evidence reports and develop recommendations for how stakeholders can apply evidence to improve the quality and value of health care. New England CEPAC directly engages clinicians, patients, and payers during public meetings to discuss implications of the evidence for clinical decision-making and coverage policies. Application of evidence takes shape through new medical policies, benefit designs, and patient and clinician tools to improve clinical care and patient outcomes.

At the December 5, 2017 meeting, the Council will review the ICER Evidence Report on treatments for Tardive Dyskinesia. TD is a serious and disabling hyperkinetic, involuntary movement disorder that includes a range of clinical manifestations. Patients may not be aware of these involuntary movements, especially when involving the face, and thus the condition can be socially stigmatizing and may impact employment. Tardive Dskyinesia affects individuals treated with antipsychotic agents given for a variety of mental health conditions.

Until recently, there were no FDA approved treatments for Tardive Dyskinesia, and only a few off-label treatment options. ICER will be evaluating the effectiveness of recently approved valbenazine and deutetrabenazine, and tetrabenazine, which is currently under evaluation by the FDA for the indication of TD.

The meeting will be held at the Boston Marriott in Newton, MA. For more information, and to view reports and meeting materials as they become available, please visit the ICER website.

Share with friends

Date and Time

Save This Event

Event Saved